Pharma Tips

Lupin to buy 21 branded drugs from Japan's Shionogi

By: Pharma Tips | Views: 898 | Date: 17-Nov-2016

Indian drugmaker Lupin Ltd said it had agreed to buy a portfolio of 21 drugs from Japan's Shionogi & Co Ltd for 15.4 billion yen ($150 million), expanding its presence in its third-largest market.

Lupin to buy 21 branded drugs from Japan's Shionogia

Indian drugmaker Lupin Ltd said it had agreed to buy a portfolio of 21 drugs from Japan's Shionogi & Co Ltd for 15.4 billion yen ($150 million), expanding its presence in its third-largest market.

The portfolio will be transferred to Lupin on Dec. 31, subject to regulatory approvals and certain closing conditions, the companies said in a statement on Tuesday.

The acquisition, which will be done by Lupin's Japanese generic drug unit Kyowa Pharmaceutical Industry Co Ltd, will give Lupin access to Japanese branded pharmaceutical market and strengthen its speciality business portfolio, they said.

The 21 products currently have sales of $90 million and cover therapy areas such as central nervous system, oncology, cardiovascular and anti-infectives, the statement said.

Lupin Ltd, India’s third largest drug maker, will buy a portfolio of 21 generic brands from Osaka-based Shionogi & Co. Ltd at the cost of US $150 million.

The move will help the company to strengthen its presence in the Japanese market, the second largest pharmaceutical market with a size of US$ 110 bn. The acquisition will make Lupin rank sixth among generic companies in Japan. The 21 products will cover therapeutic areas including Central Nervous System (CNS), oncology, cardiovascular and anti-infectives. 

Previously Lupin Ltd had made two buyouts in Japan, Kyowa Pharmaceutical Industry Co. Ltd in 2007 and I’rom Pharmaceutical Co. Ltd based out of Tokyo in 2011. Lupin earned about 10% of its total revenues to the tune of US$ 210 mn for FY16 from Japan, making it the largest Indian generic company in that country.

Japan is a tough market where Indian companies have struggled to break in, with a strong sense of brand consciousness. The Japanese government has set a target of reaching 80 per cent generic penetration by the end of the decade due to an ageing population and rising health costs, as a result opening up the domestic market to Indian pharmaceutical companies.

Previous Page Next Page

People Searching On This Page:

Related Pages


Dr. Reddy’s in $350 million deal to Buy Eight Drugs from Teva, Allergan for U.S.Market

Dr. Reddy’s in $350 million deal to Buy Eight Drugs from Teva, Allergan for U.S.Market

News | Pharma Companies
Date:
18-Jun-2016  Views: 1787

Dr. Reddy’s Laboratories will acquire a portfolio of eight Abbreviated New Drug Applications (ANDAs) in the U.S. for $350 million in cash from Teva Ph ...
B.Pharm/M.Pharm for Drugs Inspector under Directorate of Drugs control

B.Pharm/M.Pharm for Drugs Inspector under Directorate of Drugs control

Jobs | Drug Inspector
Date:
02-Mar-2016  Views: 21750

Online applications are invited from Indian Citizen and such other national as declared eligible by Government of India for recruitment to the 88 post ...
Lupin buys Mexican firm

Lupin buys Mexican firm

News | Pharma Companies
Date:
06-Apr-2015  Views: 1136

Lupin Ltd has acquired Mexico’s speciality pharmaceutical company Laboratorios Grin, for an undisclosed sum. The move marks Lupin’s entry into the Mex ...
Cipla to buy 51% stake in Yemen-based distributor for $21 mn

Cipla to buy 51% stake in Yemen-based distributor for $21 mn

News | Pharma Companies
Date:
21-Jul-2014  Views: 2375

India's second largest generic drugmaker Cipla Ltd has signed a definitive agreement to acquire a 51% stake in a pharmaceuticals manufacturing and dis ...
Drugs Inspector Job Vacancy  in Drugs Control Department of KPSC

Drugs Inspector Job Vacancy in Drugs Control Department of KPSC

Jobs | Drug Inspector
Date:
05-Jul-2012  Views: 23198

Vacancy for Drugs Inspector in Drugs Control department of KPSC - Freshers may apply ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

92  + 6 =     
Comments

Google : 10 times | Yahoo : 5 times |